Pharma channel feed

Ab­b­Vie cans oral ul­cer­a­tive col­i­tis drug from Lan­dos buy­out

Last week
R&D

So­ri­ot mulls mov­ing As­traZeneca stock list­ing to the US — re­port

Last week

Fed­er­al judge or­ders block on parts of HHS re­or­ga­ni­za­tion plan af­ter states sue

Last week
Law

PBM re­forms fail to make the cut as Sen­ate pass­es Trump’s mega­bill

Last week
R&D
FDA+

Supreme Court pass­es on Ok­la­homa’s drug mid­dle­men spat

Last week
Law

CBER chief Prasad sug­gests Covid vac­cine harms may out­weigh ben­e­fits in 'low-risk pop­u­la­tion­s'

Last week
R&D
FDA+

Hik­ma pledges $1B to ex­pand US man­u­fac­tur­ing pres­ence

Last week
Manufacturing

Uni­cy­cive gets a CRL for chron­ic kid­ney dis­ease pill as third-par­ty pro­duc­tion is­sues linger

Last week
Manufacturing

Mod­er­na's Phase 3 flu vac­cine ef­fi­ca­cy in line with com­peti­tors, tee­ing up new sub­mis­sions

Last week
R&D

J&J dealt blow in fight over its 340B re­bate mod­el

Last week
Law

FDA gives drug­mak­ers more time to sub­mit im­pu­ri­ty da­ta

Last week
R&D

In­novent brings a new mech­a­nism to obe­si­ty mar­ket with Chi­na ap­proval

Last week
China

A din­ner in Paris re­vived talks for Sanofi's $9.5B deal for Blue­print

Last week
Deals

Gilead stops RSV an­tivi­ral tri­als af­ter low in­ci­dence rates dur­ing re­cent sea­son

Last week
R&D

Judge says CVS Care­mark owes $95M in false claims case

Last week
Law

Medicare drug spend­ing will slow due to IRA price ne­go­ti­a­tions, CMS econ­o­mists pre­dict 

Last week

Ex-CBER chief Marks crit­i­cizes how FDA craft­ed its new Covid vac­cine frame­work

2 weeks ago
R&D

Trump’s CDC nom­i­nee side­steps Sen­ate grilling on con­tro­ver­sial changes

2 weeks ago
People

RFK Jr. pledges to keep the US at the cen­ter of the biotech 'rev­o­lu­tion'

3 weeks ago

RFK Jr. says he did not com­mit to up­hold­ing ACIP ros­ter to se­cure Cas­sidy’s back­ing

3 weeks ago
FDA+

UK gov­ern­ment blue­prints am­bi­tion to be a key life sci­ences hub 

3 weeks ago
R&D

As­traZeneca, Dai­ichi Sankyo gain lung can­cer in­di­ca­tion for En­her­tu suc­ces­sor

3 weeks ago
FDA+

Supreme Court asks DOJ to weigh in on Hik­ma ‘skin­ny la­bel’ fight against Amarin

3 weeks ago
Law

No­vo ends short-lived part­ner­ship with Hims over com­pound­ed obe­si­ty drugs

3 weeks ago
Startups
Health Tech
First page Previous page 12345 Next page Last page
A service from the Financial Times